Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neoplasms × Aspirin × Clear all

Phase

Status

Unknown 4 Completed 4 Active not recruiting 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lynch syndrome I (site-specific colonic cancer) 1 Liver Cirrhosis 1 Fibrosis 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Exercise 9 Standard of Care 5 Radiotherapy 4 trametinib 3 tislelizumab 3 Radiosurgery 3 Palliative Care 3 Paclitaxel 3 Drug Therapy 3 Carboplatin 3 trastuzumab deruxtecan 2 Therapeutics 2 Surveys and Questionnaires 2 Oxaliplatin 2 Maintenance 2 Magnetic Resonance Spectroscopy 2 Immune Checkpoint Inhibitors 2 Gemcitabine 2 Focus Groups 2 Data Collection 2 Cisplatin 2 Biopsy 2 Anastrozole 2 130-nm albumin-bound paclitaxel 2 vedolizumab 1 toripalimab 1 surufatinib 1 sparsentan 1 sintilimab 1 semaglutide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡